S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Critical asset just had biggest fall on record (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Critical asset just had biggest fall on record (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Critical asset just had biggest fall on record (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Critical asset just had biggest fall on record (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet

Denali Therapeutics (DNLI) SEC Filings & 10K Form

$20.86
+1.08 (+5.46%)
(As of 03/1/2024 ET)

Recent Denali Therapeutics SEC Filings

DateFilerForm TypeView
03/01/2024
3:51 PM
Denali Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
02/27/2024
7:03 AM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
7:07 AM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2024
4:38 PM
Denali Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
4:38 PM
Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
SATO VICKI L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
7:02 AM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2024
8:14 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
8:14 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
8:15 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
8:16 PM
Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
3:43 PM
Denali Therapeutics (Subject)
Ho Carole (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2024
7:22 PM
Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2024
7:17 PM
Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2024
7:18 PM
Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2024
7:19 PM
Denali Therapeutics (Subject)
Ho Carole (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
6:07 PM
BIOGEN INC. (Filed by)
Denali Therapeutics (Subject)
Form SC 13G/A
01/30/2024
5:59 AM
BAILLIE GIFFORD & CO (Filed by)
Denali Therapeutics (Subject)
Form SC 13G/A
01/30/2024
5:40 AM
Denali Therapeutics (Subject)
Temasek Holdings Ltd (0001021944) (Filed by)
Form SC 13G/A
01/18/2024
5:26 PM
Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
3:23 PM
Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/12/2024
7:18 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
4:28 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:09 PM
Denali Therapeutics (Subject)
Ho Carole (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
6:34 PM
Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
6:35 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
6:33 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
6:34 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
6:20 PM
Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
7:06 AM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
7:25 PM
Denali Therapeutics (Subject)
Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/05/2024
7:27 PM
Denali Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/05/2024
7:27 PM
Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
Krognes Steve E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/05/2024
7:21 PM
Denali Therapeutics (Subject)
Denali Therapeutics (Subject)
Ho Carole (Reporting)
Ho Carole (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/05/2024
7:23 PM
Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/05/2024
4:57 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
4:57 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
4:56 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2023
6:30 PM
Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2023
5:14 PM
Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2023
3:44 PM
Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2023
3:16 PM
Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/11/2023
4:06 PM
Cole Douglas G. (Reporting)
Denali Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/05/2023
3:31 PM
Cole Douglas G. (Reporting)
Denali Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/19/2023
3:45 PM
Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
4:26 PM
Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/25/2023
4:30 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2023
4:36 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2023
3:31 PM
Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2023
3:32 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2023
3:33 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2023
3:34 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2023
1:41 PM
Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2023
1:43 PM
Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2023
1:45 PM
Denali Therapeutics (Subject)
Ho Carole (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2023
1:47 PM
Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/17/2023
5:42 PM
Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2023
5:19 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2023
5:20 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
3:34 PM
Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
4:11 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2023
4:12 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2023
4:13 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2023
1:44 PM
Denali Therapeutics (Subject)
Ho Carole (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
1:45 PM
Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/19/2023
4:09 PM
Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2023
4:10 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
3:12 PM
Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2023
3:40 PM
Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/30/2023
4:21 PM
Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2023
4:14 PM
Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/20/2023
6:03 AM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2023
4:37 PM
Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2023
4:59 PM
Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
5:01 PM
Cole Douglas G. (Reporting)
Denali Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
5:02 PM
Denali Therapeutics (Issuer)
Harris Erik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
5:03 PM
Denali Therapeutics (Issuer)
FLATLEY JAY T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
5:04 PM
Denali Therapeutics (Issuer)
Schenkein David P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
5:04 PM
Cook Jennifer E. (Reporting)
Denali Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
5:05 PM
Denali Therapeutics (Issuer)
Klein Peter S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
5:06 PM
Denali Therapeutics (Issuer)
Tessier-Lavigne Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
5:07 PM
Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
5:08 PM
Denali Therapeutics (Issuer)
Thornberry Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
7:12 AM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2023
1:53 PM
Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/24/2023
6:10 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/20/2023
4:08 PM
Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/14/2023
5:27 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2023
5:14 AM
Denali Therapeutics (Subject)
Temasek Holdings Ltd (0001021944) (Filed by)
Form SC 13G
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:DNLI) was last updated on 3/3/2024 by MarketBeat.com Staff